close
Add to watchlist
AVI BioPharma Inc (AVII) Healthcare, Biotechnology & Drugs
AVI BioPharma, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutic products based on antisense and cancer immunotherapy technology. The company's products under various development stages comprise AVI-4658, a Phase I human clinical trial product to restore, prevent, or slow deterioration of muscle function; AVI-5038, a preclinical stage product to skip exon 50 and restore a range of associated mutations; AVI-5126, a Phase II clinical trial product for the treatment of cardiovascular restenosis; and AVI-6002 and AVI—6003, which are in Phase I clinical trials to treat diseases caused by Dengue, Ebola, Marburg, and JunÃn viruses. It has strategic alliances with Chiron Corporation; Cook Group Incorporated; Ercole Biotech, Inc.; Eleos Inc.; Charley's Fund, Inc.; and the United States Department of Defense. The company was founded in 1980 and is based in Corvallis, Oregon.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 1.32 |
| Volume | (mio) 4.32 |
| Volume Avg | 846206 |
| 52 Week High | 1.94 |
| 52 Week Low | 0.50 |
| PE | N/A |
| PE (group average) | 39 |
| EPS Year | -0.02 |
| EPS change Q/Q | -1000% |
| EPS change Q/Q Yr ago | -1000% |
| EPS change Q/Q next Q est | -1000% |
| EPS change Y/Y | -7.41% |
| REV change Q/Q | -7.74% |
| REV change Q/Q Yr ago | 1091.67% |
| EPS next Q est | -0.06 |
| EPS next Y est | -0.26 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |